PROFILPELAJAR.COM

Trapidil

Trapidil
Clinical data
Trade namesRocornal, Avantrin, Travisco
AHFS/Drugs.comInternational Drug Names
Routes of
administration		By mouth
ATC code
Legal status
Legal status
  • US: Not approved
  • In general: ℞ (Prescription only)
Identifiers
  • N,N-Diethyl-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
ECHA InfoCard100.035.834 Edit this at Wikidata
Chemical and physical data
FormulaC10H15N5
Molar mass205.265 g·mol−1
3D model (JSmol)
  • CCN(CC)c1cc(nc2n1ncn2)C
  • InChI=1S/C10H15N5/c1-4-14(5-2)9-6-8(3)13-10-11-7-12-15(9)10/h6-7H,4-5H2,1-3H3 ☒N
  • Key:GSNOZLZNQMLSKJ-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Trapidil is used in the treatment of chronic stable angina pectoris. It is currently marketed in Japan under the brand name Rocornal.[1]

An analog was assigned the codename AR 12-456.[2]

Pharmacology

Based on cell free in vitro activity assays, trapidil at therapeutic concentrations causes selective phosphorylation of cellular proteins through positive modulation of regulatory subunit RII(α/β) containing protein kinase A (PKA).[3][4] At higher, non-physiologically relevant concentrations, which are generally not achieved after administration of therapeutic doses, non-selective inhibition of phosphodiesterases occurs.[4] Further, the previous documented activities as an antagonist of platelet-derived growth factor[5] are abolished when a PKA inhibitor is administered, suggesting that these noted activities are PKA mediated.[4] At these higher concentrations,[6] additional effects have been noted including vasodilation and inhibition of platelet aggregation[7][8]

References

  1. ^ "ロコルナール錠100mg | 持田製薬株式会社". med.mochida.co.jp. Retrieved 2025-10-09.
  2. ^ Hering S, Bodewei R, Schubert B, Krause EG, Wollenberger A (1985). "Trapidil and other 5-triazolo-(1, 5-alpha)-pyrimidine derivatives as calcium channel blockers in 108CC5 cells". Biomedica Biochimica Acta. 44 (5): K37–K41. PMID 2415119.
  3. ^ Sichelschmidt OJ, Hahnefeld C, Hohlfeld T, Herberg FW, Schrör K (June 2003). "Trapidil protects ischemic hearts from reperfusion injury by stimulating PKAII activity". Cardiovascular Research. 58 (3): 602–610. doi:10.1016/S0008-6363(03)00261-X. PMID 12798433.
  4. ^ a b c Bönisch D, Weber AA, Wittpoth M, Osinski M, Schrör K (August 1998). "Antimitogenic effects of trapidil in coronary artery smooth muscle cells by direct activation of protein kinase A". Molecular Pharmacology. 54 (2): 241–248. doi:10.1124/mol.54.2.241. PMID 9687564.
  5. ^ Maresta A, Balducelli M, Cantini L, Casari A, Chioin R, Fabbri M, et al. (December 1994). "Trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, reduces restenosis after percutaneous transluminal coronary angioplasty. Results of the randomized, double-blind STARC study. Studio Trapidil versus Aspirin nella Restenosi Coronarica". Circulation. 90 (6): 2710–2715. doi:10.1161/01.cir.90.6.2710. PMID 7994812.
  6. ^ "Trapidil Professional Information (Summary of Product Characteristics/SPC)". Federal Institute for Drugs and Medical Devices (German). January 2019. Retrieved October 9, 2025.
  7. ^ Büyükafşar K, Yazar A, Düşmez D, Oztürk H, Polat G, Levent A (October 2001). "Effect of trapidil, an antiplatelet and vasodilator agent on gentamicin-induced nephrotoxicity in rats". Pharmacological Research. 44 (4): 321–328. doi:10.1006/phrs.2001.0864. PMID 11592868.
  8. ^ Liu M, Sun Q, Wang Q, Wang X, Lin P, Yang M, et al. (March–April 2014). "Effect of trapidil in myocardial ischemia-reperfusion injury in rabbit". Indian Journal of Pharmacology. 46 (2): 207–210. doi:10.4103/0253-7613.129320. PMC 3987192. PMID 24741195.
Stub icon

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by adding missing information.

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.